Send us Fan Mail

Your GLP-1 hair loss may not be from low protein or fast weight loss and the real reason could mean it never grows back on its own. Dietitian Ana Reisdorf is joined by NYU alopecia expert Dr. Kristen Lo Sicco on the warning sign and how to protect your hair on GLP-1s like Ozempic, Wegovy, Zepbound, or Retatrutide.

IN THIS EPISODE

• Why GLP-1 hair loss isn't always caused by rapid weight loss or low protein
• The 6-month shedding warning sign that means it's time to see a dermatologist
• How GLP-1s can "unmask" androgenetic alopecia (genetic hair loss)
• Low-dose oral minoxidil (LDOM) for GLP-1 shedding — does it work, and is it forever?
• The vitamin D, iron, and zinc levels that matter most for hair regrowth

ABOUT OUR GUEST
Dr. Kristen Lo Sicco, MD, is a board-certified dermatologist and full-time faculty member at NYU Langone Health's Ronald O. Perlman Department of Dermatology in New York City. With over a decade of clinical experience and more than 260 peer-reviewed publications, she is a nationally recognized alopecia expert whose practice and research focus on hair and scalp disorders. She co-hosts a show on SiriusXM Doctor Radio (Channel 110) and founded the Alopecia Justice League advocacy organization.

CONNECT WITH KRISTEN
Alopecia Justice League: https://www.alopeciajusticeleague.com
Instagram: @alopeciajusticeleague

SPONSOR
Folly — Hair support gummies for GLP-1 users. A 300-person study showed less shedding and fuller hair after 4 weeks.
FollyNutrition.com — code GLP1HUB for 20% off

📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub

*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.

*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail

Ana Reisdorf, MS, RD, talks with Dr. Robyn Pashby, clinical health psychologist and founder of Health Psychology Partners, about the mental load of weight loss - why anxiety often climbs as the scale drops, why diet rules feel impossible to release on Ozempic, Wegovy, or Zepbound, and why weight management works better as lifelong care than a finish line. If you've ever felt afraid to trust your body on a GLP-1, this conversation gives you a calmer framework for what actually matters.

IN THIS EPISODE
- Why anxiety often goes up when weight comes down on Ozempic, Wegovy, or Zepbound
- The hidden "diet backpack" that keeps people stuck in food tracking, calendar countdowns, and on/off-the-wagon thinking
- Why GLP-1 medications should be treated as one tool in a lifelong toolbox, not a permanent solution
- How to build an obesity-medicine-trained care team (physician, registered dietitian, psychologist, movement specialist)
- How to respond when family, friends, or neighbors judge your decision to use a GLP-1

ABOUT THE GUEST
Dr. Robyn Pashby is the founder of Health Psychology Partners and a clinical health psychologist with a dual-track PhD in medical and clinical psychology and nearly 20 years of clinical experience focused on weight, eating, internalized weight bias, anxiety, and relational concerns. She serves on the National Board of Directors of the Obesity Action Coalition, the American Diabetes Association's Obesity and Weight Management Advisory Group, and the Clinical Practice Committee of The Obesity Society, and holds a research faculty appointment at the Uniformed Services University of the Health Sciences. A PSYPACT-approved psychologist, she trains physicians and allied healthcare providers on weight-inclusive care and provides telehealth therapy in more than 40 states.

CONNECT WITH ROBYN
Website: https://www.healthpsychologypartners.com/
LinkedIn: https://www.linkedin.com/in/robynpashbyphd/
Instagram: @robynpashbyphd
YouTube: @robynpashbyphd

📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub

*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.

*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail

Some women aren't losing weight on max-dose GLP-1s — and the fix is dosing down, not pushing harder.

Ana Reisdorf, registered dietitian and GLP-1 user, sits down with Alex Mufson, LCSW and founder of Canary House, to unpack why high-functioning women show up as non-responders on Ozempic, Wegovy, and Zepbound. They cover the labs traditional medicine misses, why under-eating sabotages results, and how regulating the body — not suppressing appetite — is what actually moves the scale.

IN THIS EPISODE
- Why some non-responders lose more on a microdose of tirzepatide than on a maximum dose
- The ferritin, fasting insulin, and Dutch Plus markers most GLP-1 prescribers don't run
- The glucose-insulin mismatch behind weight gain that "doesn't make sense"
- Why appetite suppression isn't the goal of GLP-1 therapy — and can stall fat loss entirely
- How epigenetics, survival mode, and high-functioning caretaker patterns block GLP-1 response

ABOUT THE GUEST
Alex Mufson, a Licensed Clinical Social Worker, is the founder of Canary House, an integrative healing practice specializing in high-functioning individuals living with persistent exhaustion, pain, and unexplained symptoms despite normal or inconclusive labs. Her work focuses on nervous, immune, and metabolic regulation for people whose lives appear stable on paper but feel increasingly effortful from the inside.

CONNECT WITH ALEX
Website: https://www.canaryhousehealing.com/
Substack: https://alexmufson.substack.com/
LinkedIn: https://www.linkedin.com/in/alex-mufson-lcsw-96146b29/
Instagram: @alex.mufson, @canaryhousehealing

SPONSOR
Folly — Hair support gummies for GLP-1 users. A 300-person study showed less shedding and fuller hair after 4 weeks.
FollyNutrition.com — code GLP1HUB for 20% off

📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub

*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.

*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.